Celeris Therapeutics

United States · 20 Employees
Celeris Therapeutics is going to solve the R&D shortcomings as the pioneer in AI-driven PIC (proximity-inducing compounds) design using an innovative closed-loop engine (CelerisTx One™ platform) to develop new chemical entities (NCEs) that degrade proteins by establishing proximity to endogenous cellular mechanisms. The solutions include machine learning-driven prediction of interactions, generative design, optimization of molecular properties, and automation of laboratory devices. CelerisTx's drug pipeline is focused on CNS and oncology, targeting unmet medical needs. We also co-develop therapeutics with pharmaceutical and biotech companies. CelerisTx has so far attracted a total of EUR 18 million in committed capital from venture capital funds, which include EIC Fund, Pace Ventures Enigma, i&i biotech, Apex Ventures, R42 and longevitytech.fund. #targetedproteindegradation #degrader #ubiquitinproteasomesystem #machinelearning #CelerisOne #proximityinducingcompounds #PICs

概述

国家 United States
成立时间 2021
总部 585 glenwood ave, menlo park, california, united states
电话号码
网站 http://www.celeristx.com
LinkedIn http://www.linkedin.com/company/celeristx
Twitter https://twitter.com/celeristx
Facebook https://facebook.com/CelerisTx/
员工数 20
行业 pharmaceuticals,
简介 Celeris Therapeutics is going to solve the R&D shortcomings as the pioneer in AI-driven PIC (proximity-inducing compounds) design using an innovative closed-loop engine (CelerisTx One™ platform) to develop new chemical entities (NCEs) that degrade proteins by establishing proximity to endogenous cellular mechanisms. The solutions include machine learning-driven prediction of interactions, generative design, optimization of molecular properties, and automation of laboratory devices. CelerisTx's drug pipeline is focused on CNS and oncology, targeting unmet medical needs. We also co-develop therapeutics with pharmaceutical and biotech companies. CelerisTx has so far attracted a total of EUR 18 million in committed capital from venture capital funds, which include EIC Fund, Pace Ventures Enigma, i&i biotech, Apex Ventures, R42 and longevitytech.fund. #targetedproteindegradation #degrader #ubiquitinproteasomesystem #machinelearning #CelerisOne #proximityinducingcompounds #PICs

技术

Apache

Load Balancers

Google Analytics

Analytics and Tracking

Google Font API

Fonts

Microsoft Office 365

Other

Mobile Friendly

Other

Outlook

Email Providers

SendInBlue

Email Marketing

WordPress.org

CMS

reCAPTCHA

Captcha

常见问题

Celeris Therapeutics 在哪里?

Celeris Therapeutics 的总部位于 585 glenwood ave, menlo park, california, united states

Celeris Therapeutics 的电话号码是多少?

Celeris Therapeutics 的电话号码是

Celeris Therapeutics 的官方网站是什么?

Celeris Therapeutics 的公司官方网站是 http://www.celeristx.com

Celeris Therapeutics 是做什么的?

Celeris Therapeutics 的业务有哪些?

protac,molecular glue,deep learning,geometric deep learning,protein,ppi,proteinproteininteraction,artificial intelligence,drug builder,drug discovery,drug design,proteinligand interaction,graph neural networks

Celeris Therapeutics 的年收入是多少?

Celeris Therapeutics 的收入是 0美元

Celeris Therapeutics 有多少员工?

Celeris Therapeutics 有 20 名员工

Celeris Therapeutics 属于哪个行业?

Celeris Therapeutics 从事以下行业: pharmaceuticals

Celeris Therapeutics 使用什么技术?

Celeris Therapeutics 使用的一些流行技术包括: Apache,Google Analytics,Google Font API,Microsoft Office 365,Mobile Friendly,Outlook,SendInBlue,WordPress.org,reCAPTCHA

如何联系 Celeris Therapeutics?

Celeris Therapeutics 联系信息: 电话号码:, 网站:http://www.celeristx.com, 邮箱:h.l***@***.com

Celeris Therapeutics 的社交媒体链接是什么?

Celeris Therapeutics 领英:http://www.linkedin.com/company/celeristx,fackbook:https://facebook.com/CelerisTx/,twitte:https://twitter.com/celeristx

Celeris Therapeutics 是一家上市公司吗?

不是

Celeris Therapeutics 的最后一轮融资是什么时候?

Celeris Therapeutics在2022-10-01T00:00:00.000+00:00结束了最后一轮融资,金额达2.5M$。

谁投资 Celeris Therapeutics?

Celeris Therapeutics 有 3 家投资者,包括 、、Longevitytech.fund。

管理层

Honorine Lebraud

Business Development Manager

Chris Tame

VP, Head of Drug Discovery and London Office

Oskar Hoff

Head of Medicinal Chemistry

Alzbeta Tuerkova

Head of Computer-Aided Drug Design

Jakob Hohenberger

Co-Founder and CFO/COO

外贸获客 查找关键决策人

10亿+海关交易数据,1.2亿企业数据,2亿+企业联系人数据,1000千万真实采购商。覆盖200+个国家及地区,95%外贸重点拓展市场,可根据行业、经营范围等多方位挖掘目标客户。
免费试用

Top-ranked on G2 Crowd

全球B2B企业库 海关贸易数据 展会采购数据

工作更少,成就更大,销售更聪明

查找更多 B2B 联系人,丰富并验证记录
Email Address

全球B2B企业库

海关贸易数据

展会采购数据

Top-ranked on G2 Crowd

OR
Sign Up with Google